StockWatch
·
HomeLiveReports
Pharmaceuticals
Board Meeting6 Nov 2026, 12:22 pm

Nectar Lifesciences Board Meeting on Nov 14, 2026

AI Summary

Nectar Lifesciences Ltd has announced that a meeting of its Board of Directors is scheduled for November 14, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended September 30, 2026. The meeting will also address related matters as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 14, 2026.
  • Unaudited financial results for Q2 FY27 to be approved.
  • Matters related to financial results will be discussed.
  • Disclosure made as per SEBI Listing Regulations.
View BSE Filing
NECLIFE
Pharmaceuticals
NECTAR LIFESCIENCES LTD.

Price Impact

More from NECLIFE

AGM/EGM5 Oct, 11:17 am

Nectar Lifesciences Ltd Holds 31st AGM

Legal3 Oct, 4:20 pm

Nectar Lifesciences Faces ₹89.32 Cr Tax Demand Challenge

Insider Trading24 Sept, 10:16 pm

Nectar Lifesciences Closes Trading Window for Insider Trading

More in Board Meeting

HPBL37m ago

HCP Plastene Board Approves Unaudited Results, Management Changes, ESOPs

STRAEXPO37m ago

Sophia Traexpo Ltd Board Meeting on Nov 12, 2026 for Q2 FY27 Results

NEXOME37m ago

Nexome Capital Markets Board Approves Un-Audited Financial Results